Therapeutic apheresis for renal disorders

Therapeutic Apheresis

Volumn 3, Issue 1, 1999, Pages 25-30

  Kaplan, Andre A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Renal disorders; Therapeutic Plasma exchange

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; APHERESIS; ARTICLE; CHILD; CRYOGLOBULINEMIA; GLOMERULOSCLEROSIS; GOODPASTURE SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MULTIPLE MYELOMA; PLASMAPHERESIS; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; GLOMERULONEPHRITIS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MULTIPLE MYELOMA; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES;

EID: 0033047465     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00138.x     Document Type: Article

References (85)

1. Sakellariou G. Plasmapheresis as a therapy in specific forms of acute renal failure. Nephrol Dial Transplant 1994;9(Suppl. 4):210-8.
2. Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal disease. J Am Soc Nephrol 1996;7:367-86.
3. Kaplan AA. Therapeutic plasma exchange for renal disease. Semin Dial 1996;9:61-70.
4. Johnson JP, Moore JJ, Austin H III, Balow JE, Antonovych TT, Wilson CB. Therapy of anti-glomerular basement membrane disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 1985;64:219-27.
5. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody-mediated disease in the British Isles 1980-4. Br Med J 1986;292:301-4.
6. Simpson IJ, Doak PB, Williams LC, Blacklock HA, Hill RS, Teague CA, Herdson PB, Wilson CB. Plasma exchange in Goodpasture's syndrome. Am J Nephrol 1982;2:301-11.
7. Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB. Immunosuppression and plasma exchange in the treatment of Goodpasture's syndrome. Lancet 1976;1:711-4.
8. Lockwood CM, Rees AJ, Pinching AJ, Pussell B, Sweny P, Uff J, Peters DK. Plasma exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet 1977;1:63-7.
9. Kincaid-Smith P, D'Apice AJF. Plasmapheresis in rapidly progressive glomerulonephritis. Am J Med 1978;65:564-6.
10. Hind CRK, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ. Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet 1983;1:263-5.
11. Mauri JM, Gonzales MT, Poveda R, Seron D, Torras J, Andujar J, Andres E, Alsina J. Therapeutic plasma exchange in the treatment of rapidly progressive glomerulonephritis. Plasma Ther Transfus Technol 1985;6:587-91.
12. Glockner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, Bohle A, Daul A, Graben N, Keller F, Klehr U, Kohler H, Metz U, Schultz W, Thoenes W, Vlaho M. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: A controlled multi-center study. Clin Nephrol 1988;29:1-8.
13. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757-63.
14. Cole E, Cattran D, Magil A, Greenwood C, Churchill D, Sutton D, Clark W, Morrin P, Posen G, Bernstein K, Dyck R, Canadian Apheresis Study Group. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. Am J Kidney Dis 1992;20:261-9.
15. Kaplan AA. Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis. Ther Apheresis 1997;1:255-9.
16. Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991;324:1845-51.
17. Zucchelli P, Pasquali S, Cagnoli L, Ferrari G. Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 1988;33:1175-89.
18. Misiani R, Tiraboschi G, Mingardi G, Mecca G. Management of myeloma kidney: An anti-light chain approach. Am J Kidney Dis 1987;10:28-33.
19. Johnson WJ, Kyle RA, Pineda AA, O'Brien PC, Holley KE. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 1990;150:863-9.
20. Wahlin A, Lofvenberg E, Holm J. Improved survival in multiple myeloma with renal failure. Acta Med Scand 1987;221: 205-9.
21. Galla JH. IgA nephropathy. Kidney Int 1995;47:377-87.
22. Hene RJ, Kater L. Plasmapheresis in nephritis associated with Henoch-Schonlein purpura and in primary IgA nephropathy. Plasma Ther Transfus Technol 1983;4:165-73.
23. Coppo R, Basolo B, Roccatello D, Piccoli G. Plasma exchange in primary IgA nephropathy and Henoch-Schonlein syndrome nephritis. Plasma Ther Transfus Technol 1985;6: 705-23.
24. Coppo R, Basolo B, Giachino O, Roccatello D, Lajolo D, Mazzucco G, Amore A, Piccoli G. Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: Removal of IgA-containing circulating immune complexes and clinical recovery. Nephron 1985;40:488-90.
25. Nicholls K, Becker G, Walker R, Wright C, Kincaid-Smith P. Plasma exchange in progressive IgA nephropathy. J Clin Apheresis 1990;5:128-32.
26. Malchesky PS, Clough JD. Cryoglobulins: Properties, prevalence in disease and removal. Cleve Clin Q 1985;52:175-92.
27. Lockwood CM. Lymphoma, cryoglobulinemia and renal disease. Kidney Int 1979;16:522-30.
28. Berkman EM, Orlin JB. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion 1979;20:171-8.
29. Geltner D, Kohn RW, Gorevic P, Franklin EC. The effect of combination therapy (steroids, immunosuppressives and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic and vascular involvement. Arthritis Rheum 1981; 24:1121-7.
30. Evans TW, Nicholls AJ, Shortland JR, Ward AM, Brown CB. Acute renal failure in essential mixed cryoglobulinemia: Precipitation and reversal by plasma exchange. Clin Nephrol 1984;21:287-93.
31. Ferri C, Moriconi L, Gremignai G, Migliorini P, Paleologo G, Fosellar PV, Bombardieri S. Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron 1986;43:246-53.
32. D'Amico G, Colasanti G, Ferrario F, Sinico RA. Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989;35:1004-14.
33. D'Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 1998;54: 650-71.
34. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tfanzi E, Zanetti A. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N EnglJ Med 1994;330: 751.
35. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991;325:393-7.
36. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Clinical experience in 108 patients. N Engl J Med 1991;325:398-403.
37. Byrnes JJ, Moake JL, Klug P, Periman P. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 1990;34:169-74.
38. Remuzzi G. HUS and TIP: Variable expression of a single entity. Kidney Int 1987;32:292-308.
39. Rondeau E, Peraldi MN. Escherichia coli and the hemolytic uremic syndrome (editorial). N Engl J Med 1996;335:660-2.
40. Drummond KN. Hemolytic uremic syndrome - Then and now (editorial). N Engl J Med 1985;312:116-8.
41. Lyman NW, Michaelson R, Viscuso RL, Winn R, Mulgaonkar V, Jacobs MG. Mitomycin-induced hemolytic-uremic syndrome: Successful treatment with corticosteroids and intense plasma exchange. Arch Intern Med 1983;143:1617-8.
42. Aster RH. Quinine sensitivity: A new cause of the hemolytic uremic syndrome. Ann Intern Med 1993;119:243-4.
43. Melnyk AMS, Solez K, Kjellstrand CM. Adult hemolytic uremic syndrome: A review of 37 cases. Arch Intern Med 1995; 155:2077-84.
44. Morel-Maroger L, Kanfer A, Solez K, Sraer JD, Richet G. Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic uremic syndrome): Clinicopathologic study in 20 adults. Kidney Int 1979;15:548-58.
45. Schieppati A, Ruggenenti P, Cornejo RP, Ferrario F, Gregorini G, Zucchelli P, Rossi E, Remuzzi G. Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. J Am Soc Nephrol 1992;2:1640-4.
46. Conlon PJ, Howell DN, Macik G, Kovalik EC, Smith SR. The renal manifestations and outcome of thrombotic thrombocytopenic pupura/hemolytic uremic syndrome. Nephrol Dial Transplant 1195;10:1189-93.
47. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS, Neefe JR. Cancer associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry. J Clin Oncol 1989;7:781.
48. Korec S, Schein PS, Smith FP, Neefe JR, Wooley PV, Goldberg RM, Phillips TM. Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol 1986;4:210-5.
49. Agarwal A, Mauer SM, Matas AJ, Nath KA. Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: Current concepts and management. J Am Soc Nephrol 1995; 6:1160-9.
50. Martin DL, MacDonald KL, White K, Soler JT, Osterholm MT. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 1990;323: 1161-7.
51. Rondeau E, Peraldi MN. Escherichia coli and the hemolytic uremic syndrome (editorial). N Engl J Med 1996;335:660-2.
52. Rizzoni G, Claris-Appiani A, Edefonti A, Facchin P, Franchini F, Gusmano R, Imbasciati E, Pavanello L, Perfumo F, Ramuzzi G. Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial. J Pediatr 1988;112:284-90.
53. Gianviti A, Perna A, Caringella A, Edefonti A, Penza R, Remuzzi G, Rizzoni G. Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome. Am J Kidney Dis 1993;22:264-6.
54. Robson WLM, Leung AKC. The successful treatment of atypical hemolytic uremic syndrome with plasmapheresis. Clin Nephrol 1991;35:119-22.
55. Denneberg T, Friedberg M, Holmberg L, Mathiasen C, Nilsson KO, Takolander R, Walder M. Combined plasmapheresis and hemodialysis treatment for severe hemolytic-uremic syndrome following Campylobacter colitis. Acta Paediatr Scand 1982;71:243-5.
56. Sheth KJ, Leichter HE, Gill JC, Baumgardt A. Reversal of central nervous system involvement in hemolytic uremic syndrome by use of plasma exchange. Clin Pediatr 1987;26:651-6.
57. Jones JV, Gumming RH, Bucknall RC, Asplin CM, Fraser ID, Bothamley J, Davis P, Hamblin TJ. Plasmapheresis in the management of acute systemic lupus erythematosus? Lancet 1976;i:709-11.
58. Jones JV, Gumming RH, Bacon PA, Evers J, Fraser ID, Bothamley J, Tribe CR, Davis P, Huges GRV. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Q J Med 1979;192:555-76.
59. Jones JV, Robinson MF, Parciany RK, Layfer LF, McLeod B. Therapeutic plasmapheresis in systemic lupus erythematosus. Arthritis Rheum 1981;24:1113-20.
60. Abdou NI, Lindsley HB, Pollock A, Stechschulte DJ, Wood G. Plasmapheresis in active lupus erythematosus: Effect on clinical, serum and cellular abnormalities. Case report. Clin Immunol Immunopathol 1981;19:44-54.
61. Leaker BR, Becker GJ, Dowling JP, Kincaid-Smith PS. Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression. Clin Nephrol 1986;25:236-44.
62. Wei N, Klippel JH, Huston DP, Hall RP, Lawley TJ, Balow JE, Steinberg AD, Decker JL. Randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1983;1: 17-21.
63. French Collaborative Group. A randomized trial of plasma exchange in severe acute systemic lupus erythematosus: Methodology and interim analysis. Transfus Technol 1985;6: 535-9.
64. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM, Lupus Nephritis Collaborative Study Group. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992;326:1373-9.
65. Thomson BJ, Watson ML, Liston WA, Lambie AT. Plasmapheresis in a pregnancy complicated by acute systemic lupus erythematosus. Case report. Br J Obstet 1985;92:532-4.
66. Euler HH, Schroeder JO, Zeuner RA, Teske E. A randomized trial of plasmapheresis and subsequent pulse cyclophosphamide in severe lupus: Design of the LPSG trial. Int J Artif Organs 1991;14:639-46.
67. Schroeder JO, Euler HH, Loffler H. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med 1987;107:344-6.
68. Lupus Plasmapheresis Study Group, Circular #1/1995. Kiel, Germany: Clinical Coordinating Center, University of Kiel, 2nd Medical Clinic.
69. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 1994; 37:1784-94.
70. Euler HH, Schwab UM, Schroeder JO, Hasford J. The Lupus Plasmapheresis Study Group: Rationale and updated interim report. Artif Organs 1996;20:356-9.
71. Frampton G, Cameron JS, Thom M, Jones S, Raftery M. Successful removal of antiphospholipid antibody during pregnancy using plasma exchange and low dose prednisolone. Lancet 1987;2:1023-4.
72. Fulcher D, Stewart G, Exner T, Trudinger B, Jeremy R. Plasma exchange and the anticardiolipin syndrome in pregnancy. Lancet 1989;2:171.
73. Asherson RA, Piette JC. The catastrophic antiphospholipid syndrome 1996: Acute multi-organ failure associated with antiphospholipid antibodies: A review of 31 patients. Lupus 1996;5:414-7.
74. Farrugia E, Torres VE, Gastineau D, Michet CJ, Holley KE. Lupus anticoagulant in SLE: A clinical and renal pathological study. Am J Kidney Dis 1992;20:463-71.
75. Kincaid-Smith P, Fairley K, Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy related renal failure. Q J Med 1988;258:795-815.
76. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994;21:864-70.
77. Omote A, Muramatsu M, Sugimoto Y, Hosono S, Murakami R, Tanaka H, Watanabe Y, Sano H, Kato K. Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies-related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med 1997;36:508-13.
78. Wach F, Ullrich H, Schmitz G, Landthaler M, Hein R. Treatment of severe localized scleroderma by plasmapheresis - report of three cases. Br J Dermatol 1995;133:605-9.
79. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994;330:7-14.
80. Artero ML, Sharma R, Savin VJ, Vincenti F. Focal segmental glomerulosclerosis in renal transplants. Am J Kidney Dis 1994;23:574-81.
81. Charpentier BM, Hiesse C, Kriaa F, Rousseau P, Farahmand H, Bismuth A, Fries D. How to deal with the hyperimmunized potential recipients. Kidney Int 1992;42(Suppl. 38):S176-81.
82. Ross CN, Gaskin G, Gregor-Macgregor S, Patel AA, Davey NJ, Lechler RI, Williams G, Rees AJ, Pusey CD. Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation 1993;55:785-9.
83. Kirubakaran MG, Disney APS, Norman J, Pugsley DJ, Mathew TH. A controlled trial of plasmapheresis in the treatment of renal allograft rejection. Transplantation 1981;32: 164-5.
84. Allen NH, Dyer P, Geoghegan T, Harris K, Lee HA, Slapak M. Plasma exchange in acute renal allograft rejection. Transplantation 1983;35:425-8.
85. Bonomini V, Vangelista A, Frasca GM, Di Felice A, Liviano D'Arcangelo G. Effects of plasmapheresis in renal transplant rejection: A controlled study. Trans Am Soc Artif Intern Organs 1985;31:698-701.